APA (7th ed.) Citation

Otoya, I., Valdiviezo, N., Morante, Z., Calle, C., Ferreyra, Y., Huarcaya-Chombo, N., . . . Sahgal, P. (2024). Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer. International Journal of Breast Cancer, 2024, 1. https://doi.org/10.1155/2024/9551710

Chicago Style (17th ed.) Citation

Otoya, Iris, et al. "Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer." International Journal of Breast Cancer 2024 (2024): 1. https://doi.org/10.1155/2024/9551710.

MLA (9th ed.) Citation

Otoya, Iris, et al. "Subcutaneous Trastuzumab: An Observational Study of Safety and Tolerability in Patients With Early HER2‐Positive Breast Cancer." International Journal of Breast Cancer, vol. 2024, 2024, p. 1, https://doi.org/10.1155/2024/9551710.